CN1218726C - Heat-clearing and stagnation-dissipating particle medicine and preparation method - Google Patents

Heat-clearing and stagnation-dissipating particle medicine and preparation method Download PDF

Info

Publication number
CN1218726C
CN1218726C CN 02159281 CN02159281A CN1218726C CN 1218726 C CN1218726 C CN 1218726C CN 02159281 CN02159281 CN 02159281 CN 02159281 A CN02159281 A CN 02159281A CN 1218726 C CN1218726 C CN 1218726C
Authority
CN
China
Prior art keywords
medicine
clear paste
parched
brown
heat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN 02159281
Other languages
Chinese (zh)
Other versions
CN1437968A (en
Inventor
刘书堂
计福全
李沈明
王春民
雒文栋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jingfukang Pharmaceutical Group Co ltd
Original Assignee
CHENGDE TRADITIONAL CHINESE MEDICINE GROUP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENGDE TRADITIONAL CHINESE MEDICINE GROUP Co Ltd filed Critical CHENGDE TRADITIONAL CHINESE MEDICINE GROUP Co Ltd
Priority to CN 02159281 priority Critical patent/CN1218726C/en
Publication of CN1437968A publication Critical patent/CN1437968A/en
Application granted granted Critical
Publication of CN1218726C publication Critical patent/CN1218726C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a particle medicine for clearing heat and dissipating stagnation and a preparation technological method thereof. The medicine is composed of wine-treated rhubarb, charred betel palms, folium isatidis, northern gypsum rubrum, parched hawthorns, mint, pummelo peels, katsumada galangal seeds, patchouli, peucedanum roots, caramel malt, etc. The preparation technological process comprises the following procedures: firstly, distilling the mint, etc. so as to extract volatile oil, packing the volatile oil with a beta-cyclodextrin, and filtering distilled aqueous solution; decocting and filtering the northern gypsum rubrum, etc., and merging the northern gypsum rubrum, etc. and the filter liquor so as to concentrate into clear paste; adding alcohol into the folium isatidis, etc. to extract, filter and concentrate into clear paste; mixing, spraying and drying the two kinds of clear paste; proportioning and mixing dried fine powder, lactose, cyclodextrin inclusion complex, etc. so as to make granules in a dry way. The medicine has the functions of clearing heat, dissipating stagnation, and radically and superficially treating malaise, and is suitable for pedo-infantile dyspepsia, long hysteresis heat transmission, and affection of exogenous wind-heat, such as abdominal fullness and distention, poor appetite, nausea, vomit, irregular feces, heating, dry mouth, swelling and sore throat, nasal obstruction and rhinorrhea.

Description

The stagnant granule medicament of heat clearing awayization and preparation technology's method thereof
Technical field: the invention belongs to Chinese patent drug technique field, relate to the stagnant medicine of a kind of heat clearing awayization and preparation technology's method thereof specifically.
Background technology: at present, it is less to possess the stagnate Chinese patent medicine kind of function of heat clearing awayization, in particular for the children's aspect then still less.And stagnant be clinical commonly encountered diseases, the frequently-occurring disease of department of pediatrics in recent years, and relevant with the morbidity of multiple disease, trace it to its cause, the traditional Chinese medical science is thought this main and eating and drinking without temperance, improper feeding is relevant, its performance is in the majority with stagnant heat-transformation disease.Therefore, this is treated this commonly encountered diseases, frequently-occurring disease with regard to being badly in need of developing the medicine with removing food stagnancy, intestinal stasis relieving, heat clearing away.The present invention passes through investigation for many years, recognize that the Chinese patent medicine that has this function in the prior art comprises following a few example: 1. Chinese patent ZL93100727.5 " a kind of Chinese medicine electuary and the production technology thereof " that once disclosed, its component comprises Flos Ilicis Asprellae, smelly dung jasmine, Jambul, golden button, soda-apple nightshade herb etc.; 2. Chinese patent ZL02100471.4 recently disclosed a kind of " medicine of treatment constipation and preparation method thereof " is mainly made by Radix Et Rhizoma Rhei and Radix Glycyrrhizae extractum; 3. the most frequently used clinically is to be developed by Shenzhen pharmaceutical factory of traditional Chinese medicine the earliest, and domestic " Jian ' er Qingjie liquid " that how tame production of units is arranged mainly is made up of Flos Lonicerae, Flos Chrysanthemi, Fructus Forsythiae, Fructus Crataegi, Semen Armeniacae Amarum, Pericarpium Citri Reticulatae etc. at present.
Summary of the invention:
The objective of the invention is,, excavate motherland's medical treasure-house, enrich the stagnant Chinese patent medicine kind of heat clearing awayization, the stagnant medicine of a kind of heat clearing awayization and preparation technology's method thereof are provided for making full use of Chinese herbal medicine resource.
Technical solution of the present invention is:
A kind of heat clearing awayization granule medicament that stagnates is characterized in that it is made by the following weight proportion raw material: Radix et Rhizoma Rhei (stir-fried with wine) 100g, Semen Arecae Prepareta 224g, Folium Isatidis 224g, calcite 224g, Fructus Crataegi (parched to brown) 224g, Herba Menthae 150g, Exocarpium Citri Grandis 150g, Semen Alpiniae Katsumadai 224g, Herba Pogostemonis 150g, Radix Peucedani 150g, Fructus Hordei Germinatus (parched to brown) 224g.
A kind of process for preparing the stagnant granule medicament of above-mentioned heat clearing awayization is characterized in that being finished by following step by the prescription batching:
(1) use the beta-schardinger dextrin-inclusion after Herba Menthae, Herba Pogostemonis, Radix Peucedani, Exocarpium Citri Grandis, Semen Alpiniae Katsumadai are extracted volatile oil with vapor distillation, the aqueous solution after the distillation leaches, and medicinal residues decoct with water, and merge two filtrates;
(2) get and add Semen Arecae Prepareta, Fructus Crataegi (parched to brown), Fructus Hordei Germinatus (parched to brown) after calcite decocts with water 0.5 hour, decoct with water secondary again, collecting decoction filters, filtrate;
(3) aforesaid filtrate is merged, be concentrated into the clear paste of relative density 1.08-1.12 (50 ℃ of surveys);
(4) Folium Isatidis, Radix et Rhizoma Rhei (stir-fried with wine) are added 70% alcohol reflux secondary, merge extractive liquid, filters, and filtrate recycling ethanol, alcohol extract are concentrated into the clear paste of relative density 1.08-1.12 (50 ℃ of surveys);
(5) aforementioned two kinds of clear paste mix homogeneously are carried out spray drying;
(6) get 1 part of spray drying fine powder, add 2 parts of lactose, an amount of mix homogeneously of volatile oil beta-cyclodextrin inclusion complex and magnesium stearate, dry method is made granule, and packing is promptly.
Facts have proved to have following effect according to the stagnant granule medicament of the heat clearing awayization of such scheme preparation:
Zoopery.Rabbit Typhoid-Paratyphoid first, second triple vaccine pyrogenicity method and rat yeast pyrogenicity method are adopted in experiment, observe the refrigeration function of this medicine.The result shows: this medicine can significantly postpone the fever time of rabbit, and can significantly reduce the body temperature of rabbit and rat, and the rat that can make constipation due to dry stool defecation at short notice, and stool can become wet, thinning by doing at short notice.Laboratory observation has the effect of influenza 3 types, B virus to this medicine at cellular level, both can the direct killing extracellular virus, and the pair cell inner virus has inhibitory action again.Experiment serves as to detect index with DHT (tardy paraphilia reaction), has observed the effect of this medicine to the mouse cell immunologic function; With the serum agglutinin has been the influence of this medicine to the mouse humoral immune function that detected index observing.The result shows: this medicine can strengthen the effect of human body to DHT significantly, and the body cell immunologic function is had significant potentiation; Can strengthen the antibody horizontal of mice SRBC serum agglutinin significantly, suitable giving stung dosage the human body humoral immune function had significant potentiation.The antiinflammatory, analgesia of this medicine, effect such as antibiotic have also been observed in experiment, and the result shows all obvious effects in these areas.Multinomial zoopery shows: this medicine can to children's because of food stagnation and the heating that causes of being hard and dry prevention and therapeutical effect are preferably arranged; To influenza first 3 types, B virus kills and wounds and inhibitory action; Promote enterokinesia, tangible functions of loosening bowel relieving constipation is arranged; Raise immunity has certain antiinflammatory, antibiotic and analgesic activity.For further inquiring into the mechanism of action of this Drug therapy infantile malnutrition heat-transformation disease, the present invention has also carried out the experimentation of stagnant model mice gut hormone influence, the result shows that this medicine can improve MOT in blood and the small intestine (gastrin), GAS (motilin) content, reduce SS (somatostatin) level, illustrating that this medicine promotes the gastrointestinal peristalsis effect, may be one of its intrinsic effect.
Toxicity test.Adopt and give 20 this medicine of mouse stomach 229.5g/kg/ after day, temporary transient inappetence can occur, lazy moving, untoward reaction such as horripilation, can recover next day, 20 none death of mice, show that this medicine maximum tolerated dose is 229.5g/kg/ day, be equivalent to 112 times of people's consumption.
Clinical trial.With the Jian ' er Qingjie liquid contrast medicine, several 221 examples of the total example of II clinical trial phase, test group 110 examples wherein, matched group 111 examples, result of study shows: the test group comprehensive therapeutic effect: recover and obvious effective rate is respectively 64.55% and 27.27%, total effective rate 91.82%; The matched group comprehensive therapeutic effect is recovered and obvious effective rate is respectively 50.45% and 28.83%,, total effective rate is 79.28%.. two groups have highly significant difference (P<0.001).Several 450 examples of the total example of III clinical trial phase, test group 336 examples wherein, matched group 114 examples, result of study shows: the test group comprehensive therapeutic effect: recover and obvious effective rate is respectively 59.23% and 24.27%, total effective rate 83.93%; The matched group comprehensive therapeutic effect is recovered and obvious effective rate is respectively 38.60% and 28.95%, and total effective rate is 67.55%.Two groups have highly significant difference (P<0.001)
Compared with prior art, the present invention be prescription or preparation technology's method all with have substantive distinguishing features, not only for the stagnant Chinese patent medicine of heat clearing awayization has increased new varieties, and obtained significant effect.
The specific embodiment
Below in conjunction with embodiment the present invention is elaborated.
At first by following raw material and weight batching thereof, wherein:
Radix et Rhizoma Rhei (stir-fried with wine) 100g, Semen Arecae Prepareta 224g, Folium Isatidis 224g, calcite 224g, Fructus Crataegi (parched to brown) 224g, Herba Menthae 150g, Exocarpium Citri Grandis 150g, Semen Alpiniae Katsumadai 224g, Herba Pogostemonis 150g, Radix Peucedani 150g, Fructus Hordei Germinatus (parched to brown) 224g.
And then by the preparation of following process step:
(1) Herba Menthae, Herba Pogostemonis, Radix Peucedani, Exocarpium Citri Grandis, Semen Alpiniae Katsumadai were extracted volatile oil in 6 hours with vapor distillation.Wherein, volatile oil is with the beta-schardinger dextrin-inclusion of 10 times of amounts, the inclusion complex powder is standby; Aqueous solution after the distillation leaches, and medicinal residues add 6 times of decoctings and boiled 1.5 hours, and the filtrate after frying in shallow oil is with kind of the filtrate of winning the merging of preceding filtrate.
(2) get calcite and decoct with water 0.5 hour earlier after, add Semen Arecae Prepareta, Fructus Crataegi (parched to brown), Fructus Hordei Germinatus (parched to brown) and water again and mix and fry in shallow oil secondary, add 8 times of amounts of water at every turn, 1.5 hours, merge decocting liquid twice, filter, second kind of filtrate.
(3) aforesaid two kinds of filtrates are merged, and be condensed into first kind of clear paste that relative density is 1.08-1.12 (50 ℃ of survey).
(4) with Folium Isatidis, Radix et Rhizoma Rhei (stir-fried with wine) respectively with 70% alcohol reflux secondary of 6 times, 5 times amounts, each 1.5 hours, merge extractive liquid, filtered, and the alcohol extraction medicinal liquid is condensed into second kind of clear paste that relative density is 1.08-1.12 (50 ℃ of survey) behind the filtrate recycling ethanol again;
(5) aforementioned two kinds of clear paste are mixed, stir carry out spray drying (the spray drying condition: 150 ℃-170 ℃ of import pathogenic wind-warm, 70 ℃-80 ℃ of outlet pathogenic wind-warm, atomisation pressure is 2Kg/cm 2), get the spray drying fine powder.
(6) get spray drying fine powder and lactose by 1: 2 proportioning, add the magnesium stearate of volatile oil beta-cyclodextrin inclusion complex powder and 0.5% in right amount, mix homogeneously; squeeze through dry type and roll the granulation of formula comminutor, after the granule that sieves was done, fine powder can squeeze rolling grain once more; the granule packing, check, promptly.
This medicine has heat clearing awayization and stagnates, and the relieving exterior-interior syndrome function mainly is applicable to 1-14 year children's breast food inner product, the stagnation-derived fever affection due to external wind and heat disease of holding concurrently for a long time, and disease is seen distension and fullness in the abdomen, inappetence, nausea and vomiting, it is uncomfortable defecate, and the heating xerostomia is swallowed red pharyngalgia, the watery nasal discharge of having a stuffy nose etc.

Claims (2)

1, a kind of heat clearing awayization granule medicament that stagnates is characterized in that it is made by following raw materials by weight proportions: Radix et Rhizoma Rhei (stir-fried with wine) 100g, Semen Arecae Prepareta 224g, Folium Isatidis 224g, calcite 224g, Fructus Crataegi (parched to brown) 224g, Herba Menthae 150g, Exocarpium Citri Grandis 150g, Semen Alpiniae Katsumadai 224g, Herba Pogostemonis 150g, Radix Peucedani 150g, Fructus Hordei Germinatus (parched to brown) 224g.
2, the preparation method of the stagnant granule medicament of heat clearing awayization according to claim 1 is characterized in that:
(1) Herba Menthae, Herba Pogostemonis, Radix Peucedani, Exocarpium Citri Grandis, Semen Alpiniae Katsumadai are used the beta-schardinger dextrin-inclusion after with water vapour distillation volatile oil, the aqueous solution after the distillation leaches, and medicinal residues decoct with water, and merge two filtrates;
(2) get and add Semen Arecae Prepareta, Fructus Crataegi (parched to brown), Fructus Hordei Germinatus (parched to brown) after calcite decocts with water 0.5 hour, decoct with water secondary again, collecting decoction filters, filtrate;
(3) aforesaid filtrate is merged, be concentrated into relative density and under 50 ℃ of conditions, survey and be the clear paste of 1.08-1.12;
(4) Folium Isatidis, Radix et Rhizoma Rhei (stir-fried with wine) are added 70% alcohol reflux secondary, merge extractive liquid, filters, and filtrate recycling ethanol, alcohol extract are concentrated into relative density and survey under 50 ℃ of conditions and be the clear paste of 1.08-1.12;
(5) aforementioned two kinds of clear paste mix homogeneously are carried out spray drying;
(6) get spray drying fine powder and lactose according to 1: 2 proportioning, add an amount of volatile oil beta-cyclodextrin inclusion complex and magnesium stearate, mix homogeneously, dry method is made granule, and packing is promptly.
CN 02159281 2002-12-30 2002-12-30 Heat-clearing and stagnation-dissipating particle medicine and preparation method Expired - Lifetime CN1218726C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 02159281 CN1218726C (en) 2002-12-30 2002-12-30 Heat-clearing and stagnation-dissipating particle medicine and preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 02159281 CN1218726C (en) 2002-12-30 2002-12-30 Heat-clearing and stagnation-dissipating particle medicine and preparation method

Publications (2)

Publication Number Publication Date
CN1437968A CN1437968A (en) 2003-08-27
CN1218726C true CN1218726C (en) 2005-09-14

Family

ID=27672230

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 02159281 Expired - Lifetime CN1218726C (en) 2002-12-30 2002-12-30 Heat-clearing and stagnation-dissipating particle medicine and preparation method

Country Status (1)

Country Link
CN (1) CN1218726C (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101332254B (en) * 2007-06-28 2010-09-29 保定冀中药业有限公司 Traditional Chinese medicine composition for preventing and treating poultry respiratory disease
CN103239413A (en) * 2013-05-27 2013-08-14 内蒙古大漠药业股份有限公司 Method for large-scale production of traditional Chinese medicine powder particles
CN105056092B (en) * 2015-08-21 2019-05-03 北京汉典制药有限公司 A kind of preparation method of granule containing ginseng, Siberian cocklebur, lagehead atractylodes and its granule containing ginseng, Siberian cocklebur, lagehead atractylodes of preparation
CN109646559B (en) * 2019-03-01 2021-04-27 广东香山堂制药有限公司 Cold granules for clearing heat and relieving exterior syndrome and preparation method thereof
CN112022984A (en) * 2020-09-15 2020-12-04 河南融易健康科技有限公司 Preparation for removing food retention, preparation method and application thereof

Also Published As

Publication number Publication date
CN1437968A (en) 2003-08-27

Similar Documents

Publication Publication Date Title
CN101049424B (en) Medication for treating infection in respiratory system
CN102940673B (en) Medicine composition for treating dyspepsia
CN102872261A (en) Application of straw berry tomato in preparing medicine for treating acute cholecystitis
CN1857458A (en) Health product and medicine and their preparing method
CN1682828A (en) Yinhuang lung clearing capsule and its preparing method
CN101347605B (en) Chinese medicinal composition for treating gout and preparation method and application thereof
CN1218726C (en) Heat-clearing and stagnation-dissipating particle medicine and preparation method
CN100477996C (en) Extract of star of bethlehem and its prepn process, medicinal composition and use
CN102908403B (en) Chinese materia medica preparation for treating gout and preparation method thereof
CN103656499A (en) Traditional Chinese medicinal mixture for treating gallbladder polyps, and preparation method thereof
CN1031318C (en) Method for preparation of oral liquid of agastachis for restoring health
CN109350670A (en) The preparation method of Ynxingchao dropping pills compound
CN105250954B (en) A kind of Chinese medicine for treating IBS and preparation method thereof
CN106581236A (en) Medicinal composition for promoting gastric motility, and preparation method and application thereof
CN106421572A (en) Traditional Chinese medicine preparation for treating animal theileriosis and preparation method thereof
CN106075229A (en) A kind of Chinese medicinal composition preparation treating anemopyretic cold
CN113425782A (en) Preparation method of mussaenda pubescens heat clearing preparation
CN106038795A (en) Scoparia dulcis volatile oil extracting method and cough-relieving and asthma-relieving applications of the volatile oil
CN105582438A (en) Traditional Chinese medicine composition for treating gout and preparation method of traditional Chinese medicine composition
CN101549140B (en) Traditional Chinese medicine composition for treating AIDS and preparation method thereof
CN101199765B (en) Medicament for treating stomach disease
CN1827138A (en) Chinese medicine composition prescription for treating cardiovascular and cerebrovascular diseases and preparation technique thereof
CN114129684B (en) Traditional Chinese medicine composition and preparation method and application thereof
CN1057227C (en) Oral liquid for removing intense heat from throat and preparing process thereof
CN105125693A (en) Traditional Chinese medicine composition for treating acute gastritis and preparing method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: CHENGDE JINGFUKANG PHARMACEUTICAL GROUP CO., LTD.

Free format text: FORMER NAME OR ADDRESS: CHENGDE TRADITIONAL CHINESE MEDICINE GROUP CO., LTD.

CP03 Change of name, title or address

Address after: 067000 two lower reaches of Shuangqiao District, Hebei City, Chengde Province

Patentee after: Chengde Jingfukang Pharmaceutical Group Co.,Ltd.

Address before: 067000 two lower reaches of Shuangqiao District, Hebei City, Chengde Province

Patentee before: CHENGDE TRADITIONAL CHINESE MEDICINE GROUP Co.,Ltd.

C56 Change in the name or address of the patentee

Owner name: JINGFUKANG PHARMACEUTICAL GROUP CO., LTD.

Free format text: FORMER NAME: JINGFUKANG PHARMACEUTICAL GROUP CO., LTD., CHENGDE

CP03 Change of name, title or address

Address after: 067000 hi tech Industrial Development Zone, Hebei, Chengde

Patentee after: JINGFUKANG PHARMACEUTICAL GROUP Co.,Ltd.

Address before: 067000 two lower reaches of Shuangqiao District, Hebei City, Chengde Province

Patentee before: Chengde Jingfukang Pharmaceutical Group Co.,Ltd.

CX01 Expiry of patent term

Granted publication date: 20050914

CX01 Expiry of patent term